MedPath

Prehospital Study at the Universitair Ziekenhuis Brussel II

Not Applicable
Conditions
Stroke
Registration Number
NCT02270541
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

Interventional prospective randomized open blinded end-point (PROBE) single-center clinical trial on the evaluation of the efficacy, safety, feasibility, reliability, and cost-effectiveness of in-ambulance telemedicine for patients with suspicion of acute stroke.

Detailed Description

The purpose of PreSSUB II is to evaluate the efficacy, safety, feasibility, reliability and cost-effectiveness of in-ambulance telemedicine during Paramedic Intervention Team transportation of patients with suspicion of acute stroke.

The implementation of expert stroke support in the pre-hospital arena using in-ambulance telemedicine is an innovative approach that opens up new perspectives and allows continuous guidance by a stroke specialist throughout the acute stroke care continuum.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Emergency transportation by the Paramedic Intervention Team of the Universitair Ziekenhuis Brussel
  • Age >= 18 years
  • Suspicion of acute stroke with symptom onset < 12 h or unknown, based on any of the symptoms mentioned in the Belgian manual for medical regulation of pre-hospital care: Hemiparesis, Facial asymmetry, Speech disturbance, Sudden, severe headache, or Confusion.
Exclusion Criteria
  • Patients for whom in-ambulance telemedicine consultation would delay any diagnostic or therapeutic intervention.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Call-to-brain imaging timewithin 2 hours

Interval between emergency call and imaging of the brain by computed tomography or magnetic resonance imaging in the hospital.

Secondary Outcome Measures
NameTimeMethod
Medical events during in-ambulance telemedicinewithin 2 hours

Prevalence of medical events diagnosed and corrected during in-ambulance telemedicine (e.g. blood oxygen desaturation, arterial hypertension, arterial hypotension, hypoglycemia, hyperglycemia, cardiac arrhythmia, decreased level of consciousness, hyperthermia)

Clinical outcomeupto 12 months

Assessment of the functional status

Recanalisation therapyupto 8 hours

Proportion of patients with ischemic stroke receiving recanalization therapy (i.e. intravenous thrombolysis, endovascular therapy).

Trial Locations

Locations (1)

Universitair Ziekenhuis Brussel

🇧🇪

Brussels, Belgium

Universitair Ziekenhuis Brussel
🇧🇪Brussels, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.